{"id":"880b0134-4f6e-5b33-b7f4-f7cbd3f98729","stable_key":"f8641d02-8413-5bd8-92e9-62ad49286e81:asa-only-circulating-platelets","predicate":"inhibits","statement":"Following ingestion of 650 milligrams of acetylsalicylate as compressed tablets, platelet cyclooxygenase activity was inhibited 95% within 45 minutes, enzyme activity was observed to increase within 8 hours and reached 10% of control level by 24 hours, a pattern suggesting that only circulating platelets are affected by ingestion; enteric-coated tablets gave comparable inhibition with a delayed onset reflecting delayed appearance of acetylsalicylate in plasma, and returned to control along a similar pattern.","claim_class":"observational","status":"source_derived_draft","evidence_grade":"ungraded","direction":"negative","is_public":true,"mechanism_event_id":"a72f3e5f-5a8d-5368-9804-a9ed5f92ad9e","mechanism_event_label":"The drug catches the platelets that are in the blood at the time, and nothing else.","subject":{"id":"8ac405bf-3ea0-539a-8e5e-abf503dc7081","slug":"aspirin","display_name":"Aspirin / acetylsalicylic acid","entity_type_key":"drug"},"object":{"id":"4f47dcac-4266-59eb-8c82-90777c27f21d","slug":"cyclooxygenase-activity","display_name":"The cyclooxygenase activity of prostaglandin endoperoxide synthase","entity_type_key":"cellular_process"},"evidence_count":1,"mechanism_event":{"id":"a72f3e5f-5a8d-5368-9804-a9ed5f92ad9e","stable_key":"f8641d02-8413-5bd8-92e9-62ad49286e81:asa-only-circulating-platelets-event","event_type":"observed_intervention","label":"The drug catches the platelets that are in the blood at the time, and nothing else.","description":"Following ingestion of 650 milligrams of acetylsalicylate as compressed tablets, platelet cyclooxygenase activity was inhibited 95% within 45 minutes, enzyme activity was observed to increase within 8 hours and reached 10% of control level by 24 hours, a pattern suggesting that only circulating platelets are affected by ingestion; enteric-coated tablets gave comparable inhibition with a delayed onset reflecting delayed appearance of acetylsalicylate in plasma, and returned to control along a similar pattern.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"3cc7ab30-e6f8-51b9-8979-70f0ea692dc8","slug":"platelet","display_name":"Blood platelet","entity_type_key":"cell_type"},"role":"affected_cell","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"5739797a-3699-591b-95fd-f8b80e612713","slug":"salicylate","display_name":"Salicylate / salicylic acid","entity_type_key":"small_molecule"},"role":"co_measured_metabolite","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"6ddece9f-e884-5c44-800a-131218d7bb8b","slug":"enteric-coating","display_name":"Enteric coating of an aspirin tablet","entity_type_key":"chemical_species"},"role":"formulation_variable","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"196e612b-08c7-509f-a4ad-5b98bb0eac69","slug":"platelet-cox-recovery","display_name":"Recovery of platelet cyclooxygenase activity after aspirin","entity_type_key":"cellular_process"},"role":"followed_process","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""},{"entity":{"id":"8ac405bf-3ea0-539a-8e5e-abf503dc7081","slug":"aspirin","display_name":"Aspirin / acetylsalicylic acid","entity_type_key":"drug"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":4,"notes":""},{"entity":{"id":"4f47dcac-4266-59eb-8c82-90777c27f21d","slug":"cyclooxygenase-activity","display_name":"The cyclooxygenase activity of prostaglandin endoperoxide synthase","entity_type_key":"cellular_process"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":5,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/aspirin-research/7355437.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"01e0a159576fdabca8185271b0d6acd2e790cff32c06ba1e68906afb3a63544a\", \"start_char\": 0, \"end_char\": 909, \"text_sha256\": \"01e0a159576fdabca8185271b0d6acd2e790cff32c06ba1e68906afb3a63544a\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"High pressure liquid chromatography of plasma acetylsalicylate and salicylate with radiometric platelet cyclooxygenase assay","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"650 milligrams of aspirin as compressed or enteric-coated tablets","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Measures the parent drug and the metabolite separately alongside the enzyme effect, which is exactly the distinction this chapter turns on. Healthy subjects and a single dose.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Aspirin research collection; topical membership is not evidence of a direct clinical effect, and aspirin is recorded separately from salicylate, the metabolite it becomes.","comparator":null,"unit":null,"notes":"","entity":{"slug":"aspirin","display_name":"Aspirin / acetylsalicylic acid","entity_type_key":"drug"}},{"dimension":"organism","value_text":"Human","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"The drug catches the platelets that are in the blood at the time, and nothing else.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[asa-p7355437] Plasma acetylsalicylate and salicylate and platelet cyclooxygenase activity following plain and enteric-coated aspirin. (1980). https://pubmed.ncbi.nlm.nih.gov/7355437/ DOI: 10.1161/01.str.11.1.9","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Plasma and platelets","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"0ea62143-35bb-5a90-bdae-a59221f0eced","evidence_kind":"source_excerpt","locator":"Lines 403-414","start_line":403,"end_line":414,"excerpt":"### asa-only-circulating-platelets\nFollowing ingestion of 650 milligrams of acetylsalicylate as compressed tablets, platelet cyclooxygenase activity was inhibited 95% within 45 minutes, enzyme activity was observed to increase within 8 hours and reached 10% of control level by 24 hours, a pattern suggesting that only circulating platelets are affected by ingestion; enteric-coated tablets gave comparable inhibition with a delayed onset reflecting delayed appearance of acetylsalicylate in plasma, and returned to control along a similar pattern.\nCondition category: normal\nnutrient_topic: Aspirin research collection; topical membership is not evidence of a direct clinical effect, and aspirin is recorded separately from salicylate, the metabolite it becomes.\nplain_language: The drug catches the platelets that are in the blood at the time, and nothing else.\norganism: Human\ntissue_or_cell_type: Plasma and platelets\nexperimental_model: High pressure liquid chromatography of plasma acetylsalicylate and salicylate with radiometric platelet cyclooxygenase assay\nlimitations: Measures the parent drug and the metabolite separately alongside the enzyme effect, which is exactly the distinction this chapter turns on. Healthy subjects and a single dose.\nexposure: 650 milligrams of aspirin as compressed or enteric-coated tablets\nevidence_span: {\"source_cache\": \"artifacts/aspirin-research/7355437.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"01e0a159576fdabca8185271b0d6acd2e790cff32c06ba1e68906afb3a63544a\", \"start_char\": 0, \"end_char\": 909, \"text_sha256\": \"01e0a159576fdabca8185271b0d6acd2e790cff32c06ba1e68906afb3a63544a\"}\n[asa-p7355437] Plasma acetylsalicylate and salicylate and platelet cyclooxygenase activity following plain and enteric-coated aspirin. (1980). https://pubmed.ncbi.nlm.nih.gov/7355437/ DOI: 10.1161/01.str.11.1.9","model_system":"High pressure liquid chromatography of plasma acetylsalicylate and salicylate with radiometric platelet cyclooxygenase assay","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [asa-p7355437] Plasma acetylsalicylate and salicylate and platelet cyclooxygenase activity following plain and enteric-coated aspirin. (1980). https://pubmed.ncbi.nlm.nih.gov/7355437/ DOI: 10.1161/01.str.11.1.9","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"712cf519-cd27-5a8b-9e2f-961a98d7a27e","stable_key":"import-f8641d02-8413-5bd8-92e9-62ad49286e81","title":"Aspirin: the serine it acetylates, the enzyme that acetylation creates, the dose that separates platelet from vessel wall, and the metabolite that is a different drug (2026-09-22)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"93dd4343051c131e40d4fc3c95a978cd65478c13dcdb3f2d42507c49b09cb647","revision_id":"694e8ee7-49ca-5e6c-b58b-8ba8f82c2ad8","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}